Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.19.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Income Statement [Abstract]        
Net sales $ 5,508 $ 170,684 $ 369,690 $ 730,913
Cost of sales 930,164 1,655,905 2,327,770 3,370,275
Gross loss (924,656) (1,485,221) (1,958,080) (2,639,362)
Operating expenses        
Selling, general and administrative 1,996,054 3,003,202 4,086,944 5,403,349
Research and development 1,216,727 1,894,712 2,579,002 4,232,343
Total operating expenses 3,212,781 4,897,914 6,665,946 9,635,692
Interest expense, net 15,922,763 526,162 17,700,346 1,052,049
Net loss (20,060,200) (6,909,297) (26,324,372) (13,327,103)
Deemed dividends 86,207 765,179 86,207 765,179
Net loss attributable to common stockholders $ (20,146,407) $ (7,674,476) $ (26,410,579) $ (14,092,282)
Basic and diluted earnings per share (in usd per share) $ (0.33) $ (0.18) $ (0.44) $ (0.33)
Weighted average number of common shares outstanding 60,530,168 42,406,471 60,530,168 42,406,471